Analyst Ratings for United Therapeutics Corp. (UTHR) [Sells]
UTHR Rating Summary
UTHR Price Target Summary
- Highest: $330.00 (Leerink Partners)
- Lowest: $170.00 (BofA Securities)
- Average: $280.56
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$280.56 (+19.3%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 64%
Avg. $ Target:
$280.56 (+19.3%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 64%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/3/2019 | BofA Securities » Updated 8/3/2023 |
Greg Harrison | New Coverage | Underperform (N/A) |
170.00 (160.00) |
91.82 (235.08) |
156.02% | Details |
| 11/29/2016 | Barclays » Updated 2/28/2019 |
N/A | Downgrade | Underweight (Equalweight) |
95.00 (100.00) |
132.74 (235.08) |
77.1% | Details |
